Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated:  1/24/2014
University of Pittsburgh, Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial
Status: Enrolling
Updated: 1/24/2014
University of Pittsburgh, Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated:  1/24/2014
Cook County Health and Hospital System
mi
from
Chicago, IL
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated: 1/24/2014
Cook County Health and Hospital System
mi
from
Chicago, IL
Click here to add this to my saved trials
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated:  1/24/2014
Resurrection Medical Center
mi
from
Chicago, IL
Reducing Disparities in Late Life Depression and Metabolic Syndrome
BRIGHTEN Heart: Reducing Disparities in Late Life Depression and Metabolic Syndrome
Status: Enrolling
Updated: 1/24/2014
Resurrection Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Traditional African Healing Ceremony in a U.S. Population
Traditional African Healing Ceremony in a U.S. Population
Status: Enrolling
Updated:  2/5/2014
Duke University
mi
from
Durham, NC
Traditional African Healing Ceremony in a U.S. Population
Traditional African Healing Ceremony in a U.S. Population
Status: Enrolling
Updated: 2/5/2014
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
Status: Enrolling
Updated:  2/14/2014
Univ of Pennsylvania
mi
from
Philadelphia, PA
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
Status: Enrolling
Updated: 2/14/2014
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
An Open Label Study of the Genecept™ Assay to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression
Status: Enrolling
Updated:  2/19/2014
Genomind, LLC
mi
from
Chalfont, PA
An Open Label Study of the Genecept™ Assay in Treatment Resistant Depression
An Open Label Study of the Genecept™ Assay to Evaluate Efficacy of Using Assay Guided Treatment in Outpatient Adults With Treatment Resistant Depression
Status: Enrolling
Updated: 2/19/2014
Genomind, LLC
mi
from
Chalfont, PA
Click here to add this to my saved trials
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Status: Enrolling
Updated:  2/19/2014
Genomind, LLC
mi
from
Chalfont, PA
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay
Status: Enrolling
Updated: 2/19/2014
Genomind, LLC
mi
from
Chalfont, PA
Click here to add this to my saved trials
Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Adjunctive, Flexible-Dose Mixed Salts Amphetamine (MSA) in Adult Outpatients With Major Depressive Disorder (MDD) Responding Inadequately to Current Antidepressant Therapy (ADT)
Status: Enrolling
Updated:  3/17/2014
Rush University Medical Center
mi
from
Chicago, IL
Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Adjunctive, Flexible-Dose Mixed Salts Amphetamine (MSA) in Adult Outpatients With Major Depressive Disorder (MDD) Responding Inadequately to Current Antidepressant Therapy (ADT)
Status: Enrolling
Updated: 3/17/2014
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Status: Enrolling
Updated:  3/24/2014
Northwestern University
mi
from
Chicago, IL
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment
Status: Enrolling
Updated: 3/24/2014
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Integrative Coping Group for Children
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated:  4/21/2014
Duke Child and Family Study Center
mi
from
Durham, NC
Integrative Coping Group for Children
Treatment of Psychosomatic Pain in Youth (ToPSY): A Pilot Study
Status: Enrolling
Updated: 4/21/2014
Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.
A Randomized Study Comparing the Tennant BioModulator to Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the Symptomatic Treatment of Chronic Pain Among Injured Service Members.
Status: Enrolling
Updated:  5/19/2014
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.
A Randomized Study Comparing the Tennant BioModulator to Transcutaneous Electrical Nerve Stimulation (TENS) and Traditional Chinese Acupuncture for the Symptomatic Treatment of Chronic Pain Among Injured Service Members.
Status: Enrolling
Updated: 5/19/2014
Brooke Army Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated:  5/28/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated: 5/28/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated:  5/28/2014
University of Florida
mi
from
Gainesville, FL
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated: 5/28/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated:  5/28/2014
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated: 5/28/2014
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated:  5/28/2014
Cleveland Clinic
mi
from
Cleveland, OH
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated: 5/28/2014
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated:  5/28/2014
Oregon Health and Science University
mi
from
Portland, OR
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Repetitive Transcranial MAgnetic STimulation (rTMS) for MotoR and Mood Symptoms of Parkinson's Disease (MASTER-PD), a Multicenter Clinical Trial
Status: Enrolling
Updated: 5/28/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia
Intravenous Ibuprofen for Post-Electroconvulsive Therapy Myalgia
Status: Enrolling
Updated:  6/11/2014
University Hospital
mi
from
Newark, NJ
IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia
Intravenous Ibuprofen for Post-Electroconvulsive Therapy Myalgia
Status: Enrolling
Updated: 6/11/2014
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Adjunctive Isradipine for the Treatment of Bipolar Depression
Adjunctive Isradipine for the Treatment of Bipolar Depression
Status: Enrolling
Updated:  6/24/2014
Massachusetts General Hospital
mi
from
Boston, MA
Adjunctive Isradipine for the Treatment of Bipolar Depression
Adjunctive Isradipine for the Treatment of Bipolar Depression
Status: Enrolling
Updated: 6/24/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Neuronal Responses to Social Feedback in Major Depressive Disorder
Neuronal Responses to Social Feedback in Major Depressive Disorder
Status: Enrolling
Updated:  7/11/2014
University of Michigan
mi
from
Ann Arbor, MI
Neuronal Responses to Social Feedback in Major Depressive Disorder
Neuronal Responses to Social Feedback in Major Depressive Disorder
Status: Enrolling
Updated: 7/11/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
A Pilot Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
Status: Enrolling
Updated:  7/24/2014
Massachusetts General Hospital
mi
from
Boston, MA
A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
A Pilot Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)
Status: Enrolling
Updated: 7/24/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Status: Enrolling
Updated:  8/5/2014
Thomas Jefferson University
mi
from
Philadelphia, PA
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Low Vision Depression Prevention Trial for Age Related Macular Degeneration
Status: Enrolling
Updated: 8/5/2014
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
A Comparison of Medication Augmentation and Problem Solving Therapy
Status: Enrolling
Updated:  8/14/2014
New York State Psychiatric Institute
mi
from
New York, NY
A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
A Comparison of Medication Augmentation and Problem Solving Therapy
Status: Enrolling
Updated: 8/14/2014
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Resilience and Coping in HIV Via Internet Delivery
Optimizing Resilience and Coping in HIV Via Internet Delivery
Status: Enrolling
Updated:  8/15/2014
University of California - San Francisco
mi
from
San Francisco, CA
Optimizing Resilience and Coping in HIV Via Internet Delivery
Optimizing Resilience and Coping in HIV Via Internet Delivery
Status: Enrolling
Updated: 8/15/2014
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated:  8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
mi
from
New York, NY
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
Status: Enrolling
Updated: 8/20/2014
New York State Psychiatric Institute, 1051 Riverside Drive
mi
from
New York, NY
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
University of California, Irvine
mi
from
Irvine, CA
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
mi
from
Stanford, CA
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
mi
from
Stanford, CA
Click here to add this to my saved trials
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated:  8/21/2014
Weill-Cornell Medical College
mi
from
New York, NY
Identifying Biological Markers for Severe Depression
Identifying Biological Markers for Severe Depression
Status: Enrolling
Updated: 8/21/2014
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Depression Management at the Workplace
Influencing Employer Purchasing Behavior
Status: Enrolling
Updated:  8/27/2014
Colorado Business Group on Health
mi
from
Denver, CO
Depression Management at the Workplace
Influencing Employer Purchasing Behavior
Status: Enrolling
Updated: 8/27/2014
Colorado Business Group on Health
mi
from
Denver, CO
Click here to add this to my saved trials
Heart Failure Caregiver Study
Stress and Health in Family Caregivers of Persons With Heart Failure
Status: Enrolling
Updated:  9/25/2014
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Heart Failure Caregiver Study
Stress and Health in Family Caregivers of Persons With Heart Failure
Status: Enrolling
Updated: 9/25/2014
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Heart Failure Caregiver Study
Stress and Health in Family Caregivers of Persons With Heart Failure
Status: Enrolling
Updated:  9/25/2014
UCLA Medical Center Santa Monica
mi
from
Santa Monica, CA
Heart Failure Caregiver Study
Stress and Health in Family Caregivers of Persons With Heart Failure
Status: Enrolling
Updated: 9/25/2014
UCLA Medical Center Santa Monica
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
Status: Enrolling
Updated:  11/4/2014
Massachusetts General Hospital
mi
from
Boston, MA
Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
Status: Enrolling
Updated: 11/4/2014
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Riluzole to Treat Depression in Bipolar Disorder
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression
Status: Enrolling
Updated:  11/6/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Riluzole to Treat Depression in Bipolar Disorder
An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression
Status: Enrolling
Updated: 11/6/2014
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits
Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits
Status: Enrolling
Updated:  11/17/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
mi
from
Stanford, CA
Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits
Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits
Status: Enrolling
Updated: 11/17/2014
Stanford University, Department of Psychiatry and Behavioral Sciences
mi
from
Stanford, CA
Click here to add this to my saved trials
Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression
Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression
Status: Enrolling
Updated:  11/17/2014
Stanford University
mi
from
Stanford, CA
Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression
Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression
Status: Enrolling
Updated: 11/17/2014
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Glendale, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
National City, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Riverside, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
San Diego, CA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Fort Meyers, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Miami, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Winter Park, FL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Atlanta, GA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Smyrna, GA
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Libertyville, IL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Libertyville, IL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Schaumburg, IL
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Schaumburg, IL
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Baltimore, MD
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Flowood, MS
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
New York, NY
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Beachwood, OH
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated:  11/18/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in the Treatment of Moderate to Severe Major Depressive Disorder (MDD): a Randomized, Double-blind Phase III Study of 10 Weeks
Status: Enrolling
Updated: 11/18/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials